Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 232Lymphoma 46Lymphoma, Mantle-Cell 44Neoplasms, Plasma Cell 40Recurrence 30Lymphoma, Non-Hodgkin 29Lymphoma, Follicular 26Leukemia, Myeloid, Acute 25Lymphoma, Large B-Cell, Diffuse 22Waldenstrom Macroglobulinemia 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, B-Cell, Marginal Zone 19Leukemia, Lymphocytic, Chronic, B-Cell 19Carcinoma, Non-Small-Cell Lung 18Leukemia 15Hodgkin Disease 13Neoplasms 12Immunoglobulin Light-chain Amyloidosis 12Hematologic Neoplasms 11Unspecified Adult Solid Tumor, Protocol Specific 9Myelodysplastic Syndromes 9Lymphoma, B-Cell 9Burkitt Lymphoma 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large-Cell, Anaplastic 8Head and Neck Neoplasms 8Congenital Abnormalities 8Breast Neoplasms 8Sarcoma 7Lymphoma, Extranodal NK-T-Cell 7

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Early Intervention, Educational 2reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Tirapazamine 1Thalidomide 1Temozolomide 1Pemetrexed 1Oxaliplatin 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Filgrastim 1Enzyme-Linked Immunosorbent Assay 1Counseling 1Cisplatin 1Carboplatin 1Bortezomib 1Bevacizumab 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unspecified Childhood Solid Tumor, Protocol Specific × Bortezomib × Clear all
NCT00021216 2015-04-15

Bortezomib in Treating Children With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡